Obulkasim, A; Ylstra, B; van Essen, HF; Benner, C; Stenning, S; Langley, R; Allum, W; ... Grabsch, HI; + view all Obulkasim, A; Ylstra, B; van Essen, HF; Benner, C; Stenning, S; Langley, R; Allum, W; Cunningham, D; Inam, I; Hewitt, LC; West, NP; Meijer, GA; van de Wiel, MA; Grabsch, HI; - view fewer (2016) Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma. Oncotarget , 7 (28) pp. 44084-44095. 10.18632/oncotarget.9857.